Back to companies
Aptevo Therapeutics Inc.
APVOUSNASDAQPharmaceuticals & HealthcareAptevo Therapeutics Inc.
Revenue
—
FY2025
Operating income
-$26.3mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API